We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$122B
1-Year Est. Return
29.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.4%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$55B
AUM Growth
-$1.17B
(-2.1%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-3.49%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
1,284
New
124
Increased
431
Reduced
564
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$314M |
| 2 |
Alibaba
BABA
|
+$295M |
| 3 |
Merck
MRK
|
+$207M |
| 4 |
Comcast
CMCSA
|
+$128M |
| 5 |
HCA Healthcare
HCA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$259M |
| 2 |
Intel
INTC
|
+$192M |
| 3 |
Eli Lilly
LLY
|
+$176M |
| 4 |
Occidental Petroleum
OXY
|
+$146M |
| 5 |
Baidu
BIDU
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.36% |
| 2 | Financials | 17.28% |
| 3 | Technology | 17.22% |
| 4 | Healthcare | 11.07% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Seres Therapeutics
MCRB
$48.4M
| $285K | ﹤0.01% |
4,433
-4,940
| -53% | -$469K |
|
1052
Constellation Brands
STZ
$23.2B
| $284K | ﹤0.01% |
1,442
-300
| -17% | -$58.6K |
|
1053
Trinity Industries
TRN
$2.38B
| $277K | ﹤0.01% |
13,363
-15,570
| -54% | -$331K |
|
1054
Monster Beverage
MNST
$88.5B
| $275K | ﹤0.01% |
8,608
+3,682
| +75% | +$111K |
|
|
VIVO
1055
DELISTED
Meridian Bioscience Inc
VIVO
| $265K | ﹤0.01% |
22,281
-13,023
| -37% | -$157K |
|
1056
Exelixis
EXEL
$13.4B
| $260K | ﹤0.01% |
12,167
-8,109
| -40% | -$170K |
|
1057
Vanguard Dividend Appreciation ETF
VIG
$114B
| $259K | ﹤0.01% |
2,245
-80
| -3% | -$8.97K |
|
|
ORIT
1058
DELISTED
Oritani Financial Corp. New
ORIT
| $257K | ﹤0.01% |
14,499
-23,800
| -62% | -$398K |
|
1059
Collegium Pharmaceutical
COLL
$956M
| $256K | ﹤0.01% |
+19,443
| New | +$260K |
|
1060
Keurig Dr Pepper
KDP
$40.8B
| $254K | ﹤0.01% |
8,789
-1,430
| -14% | -$40.7K |
|
1061
Medpace
MEDP
$16.5B
| $254K | ﹤0.01% |
+3,890
| New | +$224K |
|
1062
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $253K | ﹤0.01% |
9,000
| – | – |
|
1063
Regeneron Pharmaceuticals
REGN
$80.8B
| $252K | ﹤0.01% |
805
| – | – |
|
1064
Campbell Soup
CPB
$6.87B
| $251K | ﹤0.01% |
6,269
-1
| -0% | -$39 |
|
|
AUO
1065
DELISTED
AU Optronics Corp
AUO
| $247K | ﹤0.01% |
83,574
-29,889
| -26% | -$96.6K |
|
1066
Neurocrine Biosciences
NBIX
$16.6B
| $245K | ﹤0.01% |
2,902
-11,274
| -80% | -$926K |
|
1067
RadNet
RDNT
$5.69B
| $242K | ﹤0.01% |
17,517
-17,267
| -50% | -$221K |
|
|
BDN
1068
Brandywine Realty Trust
BDN
$554M
| $241K | ﹤0.01% |
+16,807
| New | +$257K |
|
1069
Genesco
GCO
$422M
| $234K | ﹤0.01% |
+5,536
| New | +$245K |
|
|
CWEN.A
1070
DELISTED
Clearway Energy Class A
CWEN.A
| $228K | ﹤0.01% |
14,067
-26,501
| -65% | -$402K |
|
1071
Evolent Health
EVH
$447M
| $227K | ﹤0.01% |
28,570
-28,707
| -50% | -$340K |
|
1072
Kraft Heinz
KHC
$30B
| $224K | ﹤0.01% |
7,238
-177
| -2% | -$5.58K |
|
1073
Lantheus
LNTH
$6.59B
| $223K | ﹤0.01% |
7,871
-10,186
| -56% | -$259K |
|
1074
Sally Beauty Holdings
SBH
$1.58B
| $223K | ﹤0.01% |
16,700
-455,127
| -96% | -$7.44M |
|
1075
The RMR Group
RMR
$332M
| $221K | ﹤0.01% |
4,697
-3,829
| -45% | -$206K |
|
Similar funds
VAM
Schroder Investment Management Group's Q2 2019 Portfolio in Review
As of Q2 2019, Schroder Investment Management Group held 1,284 positions worth $55B, down 2.1% from $56.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Schroder Investment Management Group withdrew a net $1.92B in Q2 2019, closing 86 positions and reducing 564 holdings. Its most notable exit was First Horizon, an estimated $52.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Schroder Investment Management Group opened a new position in Alcon worth $96.4M.
- Schroder Investment Management Group's largest Q2 2019 buy was Alcon: 1,599,828 shares worth $96.4M.
- Schroder Investment Management Group added most to NetEase in Q2 2019, an estimated $314M increase.
- Schroder Investment Management Group's biggest Q2 2019 reduction was UBS Group, cutting an estimated $259M.
- Schroder Investment Management Group fully exited First Horizon in Q2 2019, selling an estimated $52.1M.
- Schroder Investment Management Group's ten largest holdings make up 19% of its $55B portfolio in Q2 2019.
- Schroder Investment Management Group opened 124 new positions and closed 86 in Q2 2019.
- Schroder Investment Management Group's portfolio value fell 2.1% quarter-over-quarter to $55B.
Based on Schroder Investment Management Group's 13F filing for Q2 2019, filed 8 Aug 2019.